Siam Bioscience
http://dbpedia.org/resource/Siam_Bioscience an entity of type: Thing
Siam Bioscience Company, Ltd. (Thai: สยามไบโอไซเอนซ์) is a Thai drug manufacturer, owned by King Maha Vajiralongkorn. In 2009, the project started with a partnership between , subsidiary of Crown Property Bureau in the reign of King Bhumibol Adulyadej, and a medical human resource and pharmaceutical technology supporter's Mahidol University. Investing around 2,000 million baht, the project proposes were bio-pharmaceutical product research and producing Thai drugs to reduce the dependence on imported drugs. In 2012, Thailand Board of Investment subsidized Siam Bioscience for 427.50 million baht.
rdf:langString
rdf:langString
Siam Bioscience
rdf:langString
Siam Bioscience
rdf:langString
Siam Bioscience
xsd:integer
68834923
xsd:integer
1105225042
xsd:date
2009-08-17
rdf:langString
rdf:langString
rdf:langString
สยามไบโอไซเอนซ์
rdf:langString
th
xsd:integer
125
rdf:langString
<thaiBaht>
1.58E8
<thaiBaht>
3.02E8
rdf:langString
Inno Biocosmed
rdf:langString
Siam Bioscience Company, Ltd. (Thai: สยามไบโอไซเอนซ์) is a Thai drug manufacturer, owned by King Maha Vajiralongkorn. In 2009, the project started with a partnership between , subsidiary of Crown Property Bureau in the reign of King Bhumibol Adulyadej, and a medical human resource and pharmaceutical technology supporter's Mahidol University. Investing around 2,000 million baht, the project proposes were bio-pharmaceutical product research and producing Thai drugs to reduce the dependence on imported drugs. The first chair of the board and the key man driving the project was , one of Siam Cement Group's directors., former managing director of SCG Chemical, and , have been CEO and managing director from the beginning. In 2012, Thailand Board of Investment subsidized Siam Bioscience for 427.50 million baht.
xsd:nonNegativeInteger
7451
xsd:date
2009-08-17
xsd:gYear
2009
xsd:nonNegativeInteger
125
rdf:langString
สยามไบโอไซเอนซ์
<thaiBaht>
1.58E8
3.02E8